# 2026-20227: Texas Pharmacy Risks Shutdown Over Ignoring Drug Abuse Warnings

2026-20227, St. Michael's Pharmacy; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-10-02; PRIA reads it as touching household money (as of 2026-10-09).

- Canonical: https://policyrisk.com/federal-register/2026-20227
- As of: 2026-10-09
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-20227
- Title: St. Michael's Pharmacy; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 62754
- Published: 2026-10-02
- Effective: unknown
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-10-09

## In one line

Texas Pharmacy Risks Shutdown Over Ignoring Drug Abuse Warnings

## Summary

St. Michael's Pharmacy in Texas had its DEA license suspended and is facing revocation because it kept filling risky drug prescriptions without fixing obvious warning signs of abuse. This affects the pharmacy’s ability to legally handle controlled substances and could impact patients relying on it. The pharmacy must now deal with these serious legal actions, which started in late 2025 and could lead to permanent closure or fines.

## Effects PRIA read

- DEA Revokes Pharmacy's Registration: cost, high. The Drug Enforcement Administration granted the Government's request and revoked St. Michael's Pharmacy's DEA Certificate of Registration No. FS0483951 after an Order to Show Cause/Immediate Suspension issued on September 10, 2025 and an RFAA filed October 20, 2025. The Texas State Board of Pharmac…
- Patients May Lose Access to Medications: cost, medium. The Order revoking St. Michael's Pharmacy's registration means patients who rely on that pharmacy for controlled‑substance prescriptions could lose access to those medications following the suspension and revocation actions that began with the OSC/ISO on September 10, 2025 and the state license rev…
- Large Quantities of Drugs Unaccounted For: cost, high. DEA investigators found that between May 1, 2023 and March 5, 2025 St. Michael's Pharmacy could not account for large quantities of controlled substances, including 43,003.5 dosage units of hydrocodone 10/325 mg (123.63% variance), 25,960 dosage units of oxycodone 30 mg (39.91% variance), and other…
- Pharmacy Dispensed Controlled Drugs Despite Red Flags: cost, high. The Agency found that from at least January 2023 through February 2025, the pharmacy repeatedly filled controlled‑substance prescriptions with multiple red flags (pattern prescribing, drugs known to be abused, highest strengths/large quantities, and patients obtaining similar drugs from multiple pr…
- Registrant Deemed in Default for Not Seeking Hearing: cost, medium. The OSC/ISO notified St. Michael's Pharmacy of the right to request a hearing within 30 days of receipt of the OSC/ISO (issued September 10, 2025); Registrant did not request a hearing and was deemed in default, which results in admission of the factual allegations. The Government filed a Request f…
- Opportunity to Seek Reconsideration of State‑License Finding: benefit, low. The Agency took official notice that the Texas pharmacy license was revoked and found the registrant lacked state authority; the Order states Registrant may dispute this finding by filing a properly supported motion for reconsideration of findings of fact within fifteen calendar days of the date of…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-20227 on federalregister.gov](https://www.federalregister.gov/documents/2026/10/02/2026-20227/st-michaels-pharmacy-decision-and-order)
- [2026-20227 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-10-02/pdf/2026-20227.pdf)

## Related
- [Previous: 2026-20226, By Grace Inc. Counseling Services; Decision and Order](https://policyrisk.com/federal-register/2026-20226)
- [Next: 2026-20229, Agency Information Collection Activities; New Collection of Information; Client…](https://policyrisk.com/federal-register/2026-20229)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-20227 (as of 2026-10-09).
